Philips' Second Quarter Results 2011 - Healthcare Sector

PhilipsPhilips delivers 4% growth in second quarter; management team takes next steps to improve growth and performance trajectory. Comparable sales up 4%, led by strong growth at Healthcare, moderate growth at Lighting. Growth markets now represent one third of Group sales.

Frans van Houten, President and CEO of Royal Philips Electronics, commented: "Our second-quarter results were impacted by near-term operational challenges, weaker markets and a significant impairment charge. We are taking necessary steps to improve performance and we are confident in the prospects of our portfolio. Healthcare performed strongly, improving earnings and growing comparable sales by 8% over last year. In Consumer Lifestyle, we are encouraged by growth in all businesses, excluding Lifestyle Entertainment, though investments in growth affected earnings in the quarter."

Business highlights

  • Philips expanded its capabilities in imaging equipment services with the acquisition of AllParts Medical, a privately owned US-based provider of imaging equipment parts and training.
  • Philips signed a Memorandum of Understanding with the Russian Sate atomic Energy Corporation, under which the two intend to locally manufacture three important imaging modalities in nuclear medicine.
  • Philips' Sleep business launched the GoLife for Women nasal pillow CPAP mask, expanding the GoLife platform that was launched earlier in the year with GoLife for Men. This platform is the first designed around the distinct features of men and women.

Financial performance

  • Currency-comparable equipment order intake grew 4% year-on-year. Equipment order growth was seen at Imaging Systems, while Patient Care & Clinical Informatics orders were lower than in Q2 2010. Equipment orders in North American markets were 10% higher than in Q2 2010. Equipments orders in markets outside of North America were 4% lower year-on-year, with growth-market equipment orders growing by 5%.
  • Comparable sales were 8% higher year-on-year, with solid sales increases in all businesses, notably high-single-digit growth at Home Healthcare and Imaging Systems. From a regional perspective, comparable sales in mature markets grew 4% year-on-year, with sales in North America 8% higher than in Q2 2010. Growth-market sales grew 22%, with notably better sales at Imaging Systems.
  • EBITA increased by EUR 60 million year-on-year to EUR 276 million, or 13:3% of sales. EBITA improvement was driven by gross margin improvements in most businesses. Excluding restructuring and acquisition-related charges, EBITA amounted to EUR 275 million, or 13.2% of sales, compared to EUR 262 million, or 12.7% of sales, in Q2 2010.

Related news articles:

About Royal Philips Electronics
Royal Philips Electronics of the Netherlands (NYSE: PHG, AEX: PHI) is a diversified health and well-being company, focused on improving people's lives through timely innovations. As a world leader in healthcare, lifestyle and lighting, Philips integrates technologies and design into people-centric solutions, based on fundamental customer insights and the brand promise of "sense and simplicity". Headquartered in the Netherlands, Philips employs over 120,000 employees with sales and services in more than 100 countries worldwide. With sales of EUR 22.3 billion in 2010, the company is a market leader in cardiac care, acute care and home healthcare, energy efficient lighting solutions and new lighting applications, as well as lifestyle products for personal well-being and pleasure with strong leadership positions in male shaving and grooming, portable entertainment and oral healthcare.

Most Popular Now

Can Language Models Read the Genome? Thi…

The same class of artificial intelligence that made headlines coding software and passing the bar exam has learned to read a different kind of text - the genetic code. That code...

Bayer and Google Cloud to Accelerate Dev…

Bayer and Google Cloud announced a collaboration on the development of artificial intelligence (AI) solutions to support radiologists and ultimately better serve patients. As part of the collaboration, Bayer will...

North West Anglia Works with Clinisys to…

North West Anglia NHS Foundation Trust has replaced two, legacy laboratory information systems with a single instance of Clinisys WinPath. The trust, which serves a catchment of 800,000 patients in North...

Shared Digital NHS Prescribing Record co…

Implementing a single shared digital prescribing record across the NHS in England could avoid nearly 1 million drug errors every year, stopping up to 16,000 fewer patients from being harmed...

Can AI Techniques Help Clinicians Assess…

Investigators have applied artificial intelligence (AI) techniques to gait analyses and medical records data to provide insights about individuals with leg fractures and aspects of their recovery. The study, published in...

AI Makes Retinal Imaging 100 Times Faste…

Researchers at the National Institutes of Health applied artificial intelligence (AI) to a technique that produces high-resolution images of cells in the eye. They report that with AI, imaging is...

SPARK TSL Acquires Sentean Group

SPARK TSL is acquiring Sentean Group, a Dutch company with a complementary background in hospital entertainment and communication, and bringing its Fusion Bedside platform for clinical and patient apps to...

Standing Up for Health Tech and SMEs: Sh…

AS the new chair of the health and social care council at techUK, Shane Tickell talked to Highland Marketing about his determination to support small and innovative companies, by having...

GPT-4 Matches Radiologists in Detecting …

Large language model GPT-4 matched the performance of radiologists in detecting errors in radiology reports, according to research published in Radiology, a journal of the Radiological Society of North America...

ChatGPT Extracts Data for Ischaemic Stro…

In an ischaemic stroke, an artery in the brain is blocked by blood clots and the brain cells can no longer be supplied with blood as a result. Doctors must...

Experts Propose Specific and Suited Guid…

Current Artificial Intelligence (AI) models for cancer treatment are trained and approved only for specific intended purposes. GMAI models, in contrast, can handle a wide range of medical data including...

A Record Year with More than 800 Exhibit…

9 - 11 April 2024, Berlin, Germany. DMEA 2024 kicks off today, focusing on the key issues in the digital transformation of the healthcare system. From now until 11 April over...